the role of combination therapy in the treatment of invasive aspergillosis as primary or salvage therapy is uncertain and warrants a prospective, controlled clinical trial.
侵袭性曲菌病的联合药物治疗是作为首选还是难治尚无定论,需要一个前瞻性对照临床实验进行证实。
certain conditions of invasive aspergillosis warrant consideration for surgical resection of the infected focus.
某些情况下的侵袭性曲菌病需要考虑外科手术切除感染灶。
invasive aspergillosis is one of common causes of death in patients with hematologic malignancies and bone marrow transplant recipients .
侵袭性曲霉病是免疫抑制患者感染条件致病真菌引起的深部真菌感染。
for invasive aspergillosis and invasive candidiasis, we give a detailed report of current clinical evidence.
对于侵袭性曲霉菌病和侵袭性念珠菌,我们就目前的临床证据给出了详细报告。
objective to construct an invasive aspergillosis (ia) model.
目的构建侵袭性曲霉病动物模型。
objective: to assess the diagnostic value of galactomannan (gm) detection by elisa in the invasive aspergillosis (ia).
目的:评价elisa法检测半乳甘露聚糖(gm)用于侵袭性曲霉病(ia)诊断的价值。
combination therapy was used as primary therapy for invasive aspergillosis in 47%, and as salvage in 80%.
的侵袭性曲霉菌感染患者采用联合治疗作为首选,80%的患者作为补救治疗。
with the emergence of new antifungal agents, immunomodulation intervention and combination therapy, the survival rate of patients with invasive aspergillosis has been improved greatly.
新的抗真菌药物、免疫调节疗法和多种联合治疗方案的出现,使得侵袭性曲霉病患者的存活率有了显着提升。
based on the strength of the randomized study, the panel recommends voriconazole for primary treatment of these very uncommon manifestations of invasive aspergillosis (b-iii).
在随机研究的力度的基础上,专家组推荐伏立康唑作为这些少见部位侵袭性曲菌病的用药首选。
voriconazole is recommended for the primary treatment of invasive aspergillosis in most patients (a-i).
伏立康唑被推荐用于大多数侵袭性曲菌病患者的首要治疗措施(a-i)。
objective the incidence of invasive aspergillosis (ia) is increasing in patients with hematological disorders and it may lead to a high mortality rate.
目的侵袭性曲霉菌病(ia)在血液病患者发病逐年增多,且伴随很高的病死率。
recently, the incidence of invasive aspergillosis is on the rise and it has become one of the major death causes in patients with immune function suppression .
近年来,侵袭性曲霉病发病率不断上升,并成为免疫抑制患者死亡的主要原因之一。
results the incidence rate of invasive aspergillosis was 1.74% (9/576). 8 cases were pulmonary aspergillosis and 1 case was cerebral aspergillosis.
结果9例患者术后并发侵袭性曲菌病,发病率为1.74%(9/576),首发感染部位为肺部8例,中枢神经系统感染1例。
treatment of invasive aspergillosis requires consideration of appropriate antifungal therapy, potential surgical management, and modulation of immunity.
侵袭性曲霉病的治疗需要考虑采取适当的抗真菌治疗、可能的手术处理和免疫调节。